PCRX Pacira Pharmaceuticals Inc

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

$57.44  +1.16 (2.06%)
As of 06/24/2022 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2011
Outstanding shares:  45,436,752
Average volume:  491,375
Market cap:   $2,557,180,403
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B3X26D8
Valuation   (See tab for details)
PE ratio:   67.88
PB ratio:   3.65
PS ratio:   4.41
Return on equity:   5.42%
Net income %:   6.62%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy